Mergers and acquisitions grabbed the spotlight in the biotech sector once again this week after Bristol Myers Squibb BMY ...

Bio-Techne Corp. closed 31.67% below its 52-week high of $85.57, which the company reached on May 15th. The stock underperformed when compared to some of its competitors Tuesday, ...

Tevogen Bio (NASDAQ:TVGN – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at D. Boral Capital in a research report issued on Tuesday,Benzinga reports. They presently have a ...

Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...

Research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for shares of Nuvation Bio in a report released on Monday, March 10th. HC Wainwright analyst R. Burns now expects ...

Bristol Myers Squibb to acquire 2seventy Bio for $5.00 per share in a $286 million all-cash deal, an 88% premium to its last ...

JERUSALEM, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ ... The congress will take place at the Roma Conventi As major U.S. stock indexes face potential weekly losses following ...

Bio (TSVT) announced a definitive merger agreement under which Bristol Myers Squibb (BMY) will acquire all of the outstanding shares ...

Explore Instil Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TIL. Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over ...

All of the common stock and warrants are to be sold by the Company. ThinkEquity is acting as sol Annovis Bio (ANVS) announced it was granted the U.S. patent covering methods for the treatment and ...

GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, ...

Instil Bio is pivoting from tumor-infiltrating lymphocytes ... Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans ...